Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00065221 · ClinicalTrials.gov registry record · Phase 2
Ginger Control of Chemotherapy Induced Nausea and Vomiting
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
NCT00065221 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 180 participants.
The verdict
NCT00065221, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
Study Summary
This is a trial to determine the safety and efficacy of ginger in reducing the prevalence and severity of chemotherapy induced nausea and vomiting.
Interventions
- DRUG Ginger
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2003-06 |
| Est. Completion | 2007-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00065221
The ClinicalTrials.gov registry entry for NCT00065221 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ginger is the first listed.
NCT00065221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00065221 about?
NCT00065221 is a clinical study titled "Ginger Control of Chemotherapy Induced Nausea and Vomiting". This is a trial to determine the safety and efficacy of ginger in reducing the prevalence and severity of chemotherapy induced nausea and vomiting.
What is the current status of trial NCT00065221?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2003-06. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00065221?
The interventions under investigation include: Ginger (DRUG).
Who is sponsoring clinical trial NCT00065221?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.